Tesamorelin is a synthetic 44-amino-acid analog of human growth-hormone-releasing hormone (GHRH) that incorporates an N-terminal acyl modification to alter peptide stability relative to the endogenous sequence. It is used in laboratory research as a defined ligand for GHRH-receptor systems and as a model for studying modified peptide pharmacology.
Because tesamorelin is a chemically modified GHRH analog, analytical characterization should address the correct sequence, terminal modification, intact mass, purity, and degradation profile.
Scientific / Analytical Profile
- Class: modified 44-amino-acid GHRH analog
- Key structural feature: N-terminal acyl modification
- Primary research target: GHRH receptor
- Analytical focus: modification state, intact mass, sequence identity, purity, and degradation
- Data-quality requirement: webpage identifiers must match the lot-specific material and COA
Batch-specific identity, purity, and analytical results should be confirmed against the applicable Certificate of Analysis and lot documentation.
Research Use Only. This material is intended solely for controlled laboratory, analytical, and scientific research. It is not for human or veterinary use or administration, diagnosis, treatment, prevention, cosmetic use, food use, or personal use.
